In preclinical models of NB, BET inhibition has been shown to downregulate MYCN expression, induce differentiation toward a neural fate, prevent proliferation, and induce cell cycle arrest and apoptosis [5, 6, 10, 11]. This evidence concerns the gene MYCN and neuroblastoma.